The members of the American Society for Radiation Oncology (ASTRO) elected seven leading radiation oncologists to ASTRO’s Board of Directors, including Howard Sandler, MD, FASTRO, as President-elect. The officers will begin their terms in October during ASTRO’s 64th Annual Meeting in San Antonio.
The American Society for Radiation Oncology (ASTRO) recently hired Chris Neumann as its new Vice President of Learning and Education, and Kirsta Suggs as its first Director of Diversity, Equity and Inclusion (DEI).
In response to consecutive weeks of significant proposed Medicare payment cuts to radiation oncology cancer care, Thomas J. Eichler, MD, Chair of American Society for Radiation Oncology (ASTRO), issued the following statement.
Dr. Chen joins a group of just 19 physicians and medical physicists who are recognized this year for their contributions to the field of radiation oncology.
The American Society for Radiation Oncology’s (ASTRO) 62nd Annual Meeting, will be held October 25-28 via an interactive virtual platform. The meeting, Global Oncology: Radiation Therapy in a Changing World, will feature reports from the latest clinical trials; panels on global oncology, health disparities and the novel coronavirus; and an immersive attendee experience in a virtual convention center. Media resources are available at www.astro.org/astro2020press.
Bruce G. Haffty, MD, associate vice chancellor for cancer programs and chair, radiation oncology at Rutgers Cancer Institute of New Jersey has been selected as the 2020 Gold Medal Award winner by the American Society for Radiation Oncology (ASTRO), a prestigious national award recognizing individuals who have made outstanding lifetime contributions in the field of radiation oncology.
Despite facing challenges such as limited access to PPE during the COVID-19 outbreak, radiation oncology clinics quickly implemented safety enhancements that allowed them to continue caring for cancer patients, according to a new national survey from the American Society for Radiation Oncology (ASTRO). All 222 physician leaders in the survey collected April 16-30 said their practices continued to provide radiation therapy, yet 85% also reported declines in patient visits, and by an average of one-third.
The American Society for Radiation Oncology (ASTRO) recently welcomed H. Timothy Hsiao, Ph.D., as its new Director of Scientific Affairs, where he will provide strategic leadership to advance the impact of research and innovation in radiation oncology through ASTRO’s research funding, fellowships, workshops and scientific collaborations with public and private partners.
10,000+ health professionals expected to attend world’s largest radiation oncology meeting ARLINGTON, Va., June 20, 2019 — The American Society for Radiation Oncology (ASTRO) will host its 61st Annual Meeting at McCormick Place in Chicago, September 15-18, 2019. The meeting…